Fotis Asimakopoulos

1.8k total citations
40 papers, 1.3k citations indexed

About

Fotis Asimakopoulos is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Fotis Asimakopoulos has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Hematology. Recurrent topics in Fotis Asimakopoulos's work include Multiple Myeloma Research and Treatments (16 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Fotis Asimakopoulos is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Fotis Asimakopoulos collaborates with scholars based in United States, Greece and Israel. Fotis Asimakopoulos's co-authors include Peiman Hematti, Athanasios Papadas, Natalie S. Callander, Chelsea Hope, Shigeki Miyamoto, Adam Pagenkopf, Jeffrey L. Jensen, Ryan A. Denu, Jaehyup Kim and Zachary Morrow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Fotis Asimakopoulos

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fotis Asimakopoulos United States 20 557 538 443 333 194 40 1.3k
Karène Mahtouk France 18 528 0.9× 831 1.5× 833 1.9× 290 0.9× 191 1.0× 34 1.5k
Ken Maes Belgium 23 396 0.7× 1.0k 1.9× 643 1.5× 265 0.8× 345 1.8× 50 1.5k
Daniel Freund Germany 13 607 1.1× 523 1.0× 193 0.4× 168 0.5× 158 0.8× 20 1.2k
Kumar Sukhdeo United States 12 565 1.0× 969 1.8× 357 0.8× 169 0.5× 199 1.0× 28 1.5k
Liat Drucker Israel 20 320 0.6× 537 1.0× 248 0.6× 109 0.3× 203 1.0× 71 1.1k
Philippe Quittet France 22 501 0.9× 416 0.8× 750 1.7× 456 1.4× 169 0.9× 49 1.6k
Jingda Xu China 17 643 1.2× 771 1.4× 141 0.3× 390 1.2× 242 1.2× 24 1.4k
Chlöe Milsom Canada 21 310 0.6× 664 1.2× 322 0.7× 139 0.4× 353 1.8× 30 1.3k
Jacqueline E. Noll Australia 15 421 0.8× 549 1.0× 202 0.5× 144 0.4× 239 1.2× 23 923

Countries citing papers authored by Fotis Asimakopoulos

Since Specialization
Citations

This map shows the geographic impact of Fotis Asimakopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fotis Asimakopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fotis Asimakopoulos more than expected).

Fields of papers citing papers by Fotis Asimakopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fotis Asimakopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fotis Asimakopoulos. The network helps show where Fotis Asimakopoulos may publish in the future.

Co-authorship network of co-authors of Fotis Asimakopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Fotis Asimakopoulos. A scholar is included among the top collaborators of Fotis Asimakopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fotis Asimakopoulos. Fotis Asimakopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emmerich, Philip B., Linda Clipson, Cheri A. Pasch, et al.. (2025). Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8+ T Cells in Breast Cancer. Cancers. 17(9). 1435–1435.
2.
Papadas, Athanasios, et al.. (2023). Emerging roles for tumor stroma in antigen presentation and anti-cancer immunity. Biochemical Society Transactions. 51(6). 2017–2028. 3 indexed citations
3.
Brubaker, Aleah L., Marcus A. Urey, Justin Parekh, et al.. (2023). Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-in-world experience. American Journal of Transplantation. 23(2). 291–293. 6 indexed citations
4.
Yu, Mei, Yun Zhou, Terra L. Lasho, et al.. (2023). Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses. Oncogene. 42(21). 1751–1762. 4 indexed citations
5.
Papadas, Athanasios, Gauri Deb, Adam Officer, et al.. (2022). Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment. Cell Reports. 40(7). 111201–111201. 21 indexed citations
6.
D’Angelo, Christopher R., Sailendharan Sudakaran, Fotis Asimakopoulos, et al.. (2022). Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma. Leukemia & lymphoma. 64(1). 87–97. 18 indexed citations
7.
Deichaite, Ida, Tyler J. Nelson, Brent S. Rose, et al.. (2022). Differential regulation of TNFα and IL-6 expression contributes to immune evasion in prostate cancer. Journal of Translational Medicine. 20(1). 527–527. 18 indexed citations
8.
Wen, Zhi, Oisun Jung, Xiaona You, et al.. (2022). Ponatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model. Scientific Reports. 12(1). 10616–10616. 7 indexed citations
9.
Papadas, Athanasios & Fotis Asimakopoulos. (2020). Versican in the Tumor Microenvironment. Advances in experimental medicine and biology. 1272. 55–72. 20 indexed citations
10.
Emmerich, Philip B., Kristina A. Matkowskyj, Stephanie M. McGregor, et al.. (2020). VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments.. Journal of Clinical Oncology. 38(15_suppl). 3127–3127. 4 indexed citations
11.
Markovina, Stephanie, Natalie S. Callander, Shelly M. Wuerzberger‐Davis, et al.. (2017). Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma. Journal of Biological Chemistry. 293(7). 2452–2465. 35 indexed citations
12.
Papadas, Athanasios & Fotis Asimakopoulos. (2017). Mechanisms of Resistance in Multiple Myeloma. Handbook of experimental pharmacology. 249. 251–288. 21 indexed citations
13.
Hope, Chelsea, Simon J. Foulcer, Justin C. Jagodinsky, et al.. (2016). Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood. 128(5). 680–685. 115 indexed citations
14.
Jensen, Jeffrey L., Alexander L. Rakhmilevich, Erika Héninger, et al.. (2015). Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. Cancer Immunology Research. 3(8). 881–890. 22 indexed citations
15.
Callander, Natalie S., Edmond W. K. Young, KyungMann Kim, et al.. (2015). MicroC3: an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells. Integrative Biology. 7(6). 643–654. 39 indexed citations
16.
Yu, Wei, Ryan A. Denu, Kimberly A. Krautkramer, et al.. (2015). Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. Journal of Biological Chemistry. 291(7). 3268–3279. 75 indexed citations
17.
Jensen, Jeffrey L., Chelsea Hope, & Fotis Asimakopoulos. (2015). Deploying myeloid cells against myeloma. OncoImmunology. 5(3). e1090076–e1090076. 2 indexed citations
18.
Hope, Chelsea, Erika Héninger, Jeffrey L. Jensen, et al.. (2014). TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood. 123(21). 3305–3315. 75 indexed citations
19.
Asimakopoulos, Fotis, Jaehyup Kim, Ryan A. Denu, et al.. (2013). Macrophages in multiple myeloma: emerging concepts and therapeutic implications. Leukemia & lymphoma. 54(10). 2112–2121. 37 indexed citations
20.
Asimakopoulos, Fotis, Svetlana Krichevsky, Eitan Fibach, et al.. (1999). ABL1 Methylation Is a Distinct Molecular Event Associated With Clonal Evolution of Chronic Myeloid Leukemia. Blood. 94(7). 2452–2460. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karène Mahtouk Breakdown of academic impact, for papers by Ken Maes Breakdown of academic impact, for papers by Daniel Freund Breakdown of academic impact, for papers by Kumar Sukhdeo Breakdown of academic impact, for papers by Liat Drucker Breakdown of academic impact, for papers by Philippe Quittet Breakdown of academic impact, for papers by Jingda Xu Breakdown of academic impact, for papers by Chlöe Milsom Breakdown of academic impact, for papers by Jacqueline E. Noll
Rankless by CCL
2026